116 related articles for article (PubMed ID: 4209648)
1. Normal serum triiodothyronine concentration and the lack of TSH response to TRH in patients with euthyroid Graves' disease.
Shimizu T; Shishiba Y
Endocrinol Jpn; 1973 Oct; 20(5):527-8. PubMed ID: 4209648
[No Abstract] [Full Text] [Related]
2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
3. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
Clifton-Bligh P; Silverstein GE; Burke G
J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
[No Abstract] [Full Text] [Related]
4. Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs.
Ormston BJ; Alexander L; Evered DC; Clark F; Bird T; Appleton D; Hall R
Clin Endocrinol (Oxf); 1973 Oct; 2(4):369-76. PubMed ID: 4128973
[No Abstract] [Full Text] [Related]
5. A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.
Iitaka M; Ishii J; Ishikawa N; Yoshimura H; Momotani N; Saitou H; Ito K
Endocrinol Jpn; 1991 Dec; 38(6):667-71. PubMed ID: 1688049
[TBL] [Abstract][Full Text] [Related]
6. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies on regulatory system of thyroid hormone secretion and serum triiodothyronine. Part. I. Solid-state radioimmunoassy for human serum TSH and its clinical application (author's transl)].
Takeda Y
Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):18-35. PubMed ID: 807487
[TBL] [Abstract][Full Text] [Related]
8. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
Wenzel KW
Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821
[TBL] [Abstract][Full Text] [Related]
9. Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease.
Tamai H; Suematsu H; Ikemi Y; Kuma K; Matsuzuka F; Kumagai LF; Shizume K; Nagataki S
J Clin Endocrinol Metab; 1978 Sep; 47(3):475-9. PubMed ID: 122407
[TBL] [Abstract][Full Text] [Related]
10. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
Haug E; Frey HM; Sand T
Acta Endocrinol (Copenh); 1977 Jun; 85(2):335-44. PubMed ID: 405834
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
[TBL] [Abstract][Full Text] [Related]
12. Alterations in circulating thyroid hormones and thyrotropin in euthyroid patients with Graves' disease after total thyroidectomy: comparison between responders and nonresponders to TSH-releasing hormone.
Tamai H; Mori K; Matsubayashi S; Hirota Y; Kobayashi A; Matsuzuka F; Kuma K; Kumagai LF; Nagataki S
Metabolism; 1985 Nov; 34(11):1024-8. PubMed ID: 3932818
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3.
Burman KD; Dimond RC; Earll JM; Wright FD; Wartofsky L
J Clin Endocrinol Metab; 1976 Sep; 43(3):606-13. PubMed ID: 989049
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating immunoglobulins and the control of thyroid function.
Clague R; Mukhtar ED; Pyle GA; Nutt J; Clark F; Scott M; Evered D; Smith BR; Hall R
J Clin Endocrinol Metab; 1976 Sep; 43(3):550-6. PubMed ID: 821961
[TBL] [Abstract][Full Text] [Related]
15. Serum immunoglobulin G4 levels and Graves' disease phenotype.
Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay of thyrotropin-releasing hormone in euthyroid subjects and in patients with thyroid diseases.
Földes J; Mohari K; Janoki G; Tarjan G; Varga F
Acta Med Austriaca; 1992; 19 Suppl 1():83-5. PubMed ID: 1519462
[TBL] [Abstract][Full Text] [Related]
17. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].
Lorcy Y; Heim J; Auvray E; Allannic H
Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739
[TBL] [Abstract][Full Text] [Related]
18. Stimulation with thyrotrophin-releasing hormone (TRH) during antithyroid treatment.
Lauridsen UB; Kirkegaard C; Friis T; Siersbaek-Nielsen K
Acta Endocrinol (Copenh); 1975 Mar; 78(3):461-7. PubMed ID: 47216
[TBL] [Abstract][Full Text] [Related]
19. Failure of pituitary response to thyrotrophin-releasing hormone in euthyroid Graves' disease.
Lawton NF; Ekins RP; Nabarro JD
Lancet; 1971 Jul; 2(7714):14-6. PubMed ID: 4103663
[No Abstract] [Full Text] [Related]
20. Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3).
Sanchez-Franco F; García MD; Cacicedo L; Martin-Zurro A; Escobar del Ray F; Morreale de Escobar G
J Clin Endocrinol Metab; 1974 Jun; 38(6):1098-102. PubMed ID: 4208806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
